Shutao Zheng

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Molecular biomedicine

Cancers

Journal of physiology and biochemistry

Cancer cell international

State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence

Xinjiang Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Apr 07 2018

China

Associate Researcher :: State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence

Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, P.R. China Oct 01 2010

China

Associate Researcher :: Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, P.R. China

Education History

Xinjiang Medical University Sep 01 2013 - Jul 01 2016

China

PHD :: Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, P.R. China

Xinjiang University Sep 01 2005 - Jul 01 2008

China

MSC :: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, P.R. China

Xinjiang University Sep 01 2001 - Jul 01 2005

China

BSC :: Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, P.R. China

Publications

Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Shuo He, Yan Liang, Qing Liu, Tao Liu, Yiyi Tan, Tianyuan Peng, Conggai Huang, Haidong Gao, Xiaomei Lu
NME4 suppresses NFκB2-CCL5 axis, restricting CD8+ T cell tumour infiltration in oesophageal squamous cell carcinoma. Immunology (2024)
Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 5 (1) (2024)
Shutao Zheng, Yan Liang, Yiyi Tan, Lu Li, Qing Liu, Tao Liu, Xiaomei Lu
Small Tweaks, Major Changes: Post-Translational Modifications That Occur within M2 Macrophages in the Tumor Microenvironment. Cancers 14 (22) (2022)
Shutao Zheng, Yan Liang, Lu Li, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei Lu
Revisiting the Old Data of Heat Shock Protein 27 Expression in Squamous Cell Carcinoma: Enigmatic HSP27, More Than Heat Shock. Cells 11 (10) (2022)
Tao Liu, Xiujuan Han, Shutao Zheng, Qing Liu, Aerziguli Tuerxun, Qiqi Zhang, Lifei Yang, Xiaomei Lu
CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma. Cancer cell international 21 (1) (2021)
Shutao Zheng, Qing Liu, Tao Liu, Xiaomei Lu
Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered. Journal of physiology and biochemistry 77 (3) (2021)
Shutao Zheng, Tongxue Shen, Qing Liu, Tao Liu, Aerziguli Tuerxun, Qiqi Zhang, Lifei Yang, Xiujuan Han, Xiaomei Lu
CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway. Journal of cellular physiology 236 (7) (2020)
Shutao Zheng, Tao Liu, Qing Liu, Lifei Yang, Qiqi Zhang, Xiujuan Han, Tongxue Shen, Xiao Zhang, Xiaomei Lu
Widely targeted metabolomic analyses unveil the metabolic variations after stable knock-down of NME4 in esophageal squamous cell carcinoma cells. Molecular and cellular biochemistry 471 (1-2) (2020)

Shutao Zheng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shutao Zheng